Ugro Capital Ltd (UGROCAP)
🎯 Key Takeaways
- UGRO Capital is in a strategic transition phase, shifting from a high-growth but cost-intensive model to a more stable, cash-generative business with improved unit economics and targeted profitability expansion. Management is focused on operational efficiency, cost rationalization, and leveraging structural tailwinds in secured lending and merchant finance to drive sustainable AUM growth without dilutive capital raises.
- Revenue declined 18.1% QoQ to ₹497 in Q1FY27.
- ⚠️ The proposed amalgamation with Profectus Capital requires approval from both shareholders and creditors; any delay or rejection could stall strategic
- Market Cap
- ₹1,241
- P/B Ratio
- 0.43
- Debt/Equity
- 3.71
- Promoter
- 2.9%
📖 The Story
UGRO Capital is in a strategic transition phase, shifting from a high-growth but cost-intensive model to a more stable, cash-generative business with improved unit economics and targeted profitability expansion. Management is focused on operational efficiency, cost rationalization, and leveraging structural tailwinds in secured lending and merchant finance to drive sustainable AUM growth without dilutive capital raises.
📰 What's Happening
In Q1'FY27, UGRO Capital reported a 59% YoY surge in AUM to INR 15,013 crores, driven by growth in Emerging Market secured lending and Embedded Merchant Finance (GROx), now constituting 46% of AUM. Operating expenses declined 42% QoQ to INR 119 crores, cost of borrowing fell 41 bps to 10.14%, and GNPA remained contained at 2.1%. The company achieved a milestone of INR 1,000 crores in monthly disbursements. Concurrently, it approved INR 380 crores in non-convertible debentures via private placement at 10.20% coupon, maturing in August 2031, and is advancing a scheme of amalgamation with Profectus Capital, requiring shareholder and creditor approvals at meetings scheduled for 22 September 2026. Management targets 25% CAGR AUM growth through FY29 and ROA expansion to 3-3.5% post-normalization.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Revenue | 461 | 607 | 497 |
| Operating Profit | 18 | 46 | 24 |
| OPM % | 3.8% | 7.6% | 4.8% |
| Net Profit | 46 | 51 | 68 |
| EPS | ₹3.25 | ₹3.35 | ₹4.44 |
Quarterly revenue has shown volatility, declining from INR 607 crores in Mar 2026 to INR 497 crores in Jun 2026, yet operating profit margin improved to 4.8% from 3.8% in Dec 2025, reflecting cost discipline and higher yield realization. Net profit rose to INR 68 crores in Jun 2026 from INR 46 crores in Dec 2025, despite lower revenue, indicating improved operational efficiency. EPS increased to INR 4.44 in Jun 2026 from INR 3.25 in Dec 2025, signaling better profitability per share. This margin expansion aligns with management’s focus on cost reduction and asset quality improvement, even amid fluctuating revenue volumes.
🔮 Management Outlook & What's Next
Management projects ROA to improve from 2.1% to 3-3.5% following operational normalization, underpinned by structural cost reductions and higher-yielding asset growth. AUM is expected to grow at a 25% CAGR through FY29, driven by continued expansion in secured lending and embedded finance segments. The company is prioritizing organic growth without new equity raises, focusing instead on disciplined capital allocation and leverage management through instruments like NCDs and potential merger synergies.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Equity Capital | 153 |
| Reserves | 2,751 |
| Borrowings | 10,782 |
| Total Liabilities | 14,075 |
| Fixed Assets | 536 |
| Investments | 737 |
| Total Assets | 14,075 |
The balance sheet shows total assets of INR 14,075 crores as of Mar 2026, funded by equity of INR 153 crores and reserves of INR 2,751 crores, alongside substantial borrowings of INR 10,782 crores. The company is actively deploying debt to fund growth, as evidenced by the INR 380 crores NCD issuance, but maintains a relatively stable asset base with strong collateral coverage. The proposed first-ranking charge on assets for debenture repayment underscores a structured approach to secured financing, supporting long-term funding needs while preserving financial flexibility.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +214 |
| Investing | -1,964 |
| Financing | +2,751 |
| Net Cash Flow | +1,000 |
👥 Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 1.7% | 2.0% | 2.9% |
| FII | 22.8% | 22.3% | 5.5% |
| DII | 1.4% | 1.7% | 1.9% |
| Public | 22.7% | 23.6% | 24.6% |
| # Shareholders | 39,150 | 38,788 | 38,742 |
Shareholding patterns indicate a significant shift: promoter holding remains low at 1.7-2.88%, while FII participation has declined sharply from 22.33% in Q4FY26 to 5.45% in Q1FY27, suggesting reduced institutional confidence or re-rating. DII holding is also minimal at 1.85%. However, the number of shareholders has remained stable around 38,700-39,150, indicating retail stability. The dilution from NCD allotment and potential merger-related equity changes may further impact dilution dynamics, though no promoter buyback or significant accumulation is evident.
⚖️ Peer Comparison — Finance
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| BAJFINANCE | 6.13 L Cr | 30.2 | 10.4% | — | 3.82 |
| BAJAJFINSV | 2.80 L Cr | 27.5 | 11.4% | — | 5.50 |
| SHRIRAMFIN | 2.30 L Cr | 17.3 | 11.5% | — | 3.80 |
| ICICIAMC | 1.59 L Cr | 31.8 | 111.5% | — | 0.00 |
| JIOFIN | 1.45 L Cr | 68.4 | 2.3% | — | 0.17 |
| CHOLAFIN | 1.40 L Cr | 24.2 | 9.3% | — | 6.93 |
| TATACAP | 1.39 L Cr | 25.4 | 8.4% | — | 5.28 |
| BAJAJHLDNG | 1.21 L Cr | 13.6 | 12.4% | — | 0.00 |
| MUTHOOTFIN | 1.11 L Cr | 9.8 | 14.4% | — | 3.88 |
| PFC | 1.09 L Cr | 4.2 | 9.8% | — | 7.62 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. The proposed amalgamation with Profectus Capital requires approval from both shareholders and creditors; any delay or rejection could stall strategic consolidation. 2. Rising leverage due to NCD issuance at 10.20% cost increases financial risk, especially if operating cash flows weaken amid revenue volatility. 3. Dependence on secured lending and merchant finance exposes the company to sector-specific credit and macroeconomic risks, despite improving asset quality (GNPA at 2.1%). 4. Low promoter stake and declining FII interest may limit investor support during periods of uncertainty or capital needs.
📋 Recent Filings
- 🔴 Announcement2026-09-28UGRO Capital announced the resignation of its Company Secretary and Compliance Officer, Satish Kumar, effective September 28, 2026, to pursue external…
- 🔴 Corporate Action2026-09-25UGRO Capital announced on September 25, 2026, that its Investment and Borrowing Committee approved the allotment of Commercial Papers under Regulation…
- 🔴 Announcement2026-09-23UGRO Capital announced a virtual analyst meeting on September 28, 2026, to discuss its September 2026 Rising Stars conference, inviting market partici…
- 🔴 Corporate Action2026-09-17UGRO Capital announced on September 17, 2026, that its Investment and Borrowing Committee approved the allotment of Commercial Papers under Regulation…
- 🔴 Announcement2026-09-16UGRO Capital announced it raised INR 380 crore from FMO through 38,000 NCDs, marking its third investment in three years. The funding deepens developm…
- 🔴 Corporate Action2026-09-09UGRO Capital announced on September 9, 2026, that its Investment and Borrowing Committee approved the allotment of Commercial Papers with a face value…
- 🔴 Corporate Action2026-08-28UGRO Capital approved allotment of 38,000 non-convertible debentures with a face value of INR 1,00,000 each, aggregating to INR 380 crores through pri…
- 🔴 Corporate Action2026-08-19UGRO Capital Limited announced on 2026-08-19 that it will hold separate meetings of equity shareholders, secured creditors, and unsecured creditors to…
- 🔴 Corporate Action2026-08-18UGRO Capital announced the convening of separate meetings of equity shareholders, secured creditors, and unsecured creditors to approve the Scheme of …
- 🔴 Corporate Action2026-08-17UGRO Capital approved the allotment of Commercial Papers on 17 August 2026, with a face value of ₹5 lakh each, issue price of ₹489,027 per paper, and …
🧠 Analyst's Read
UGRO Capital is executing a deliberate transformation toward a more efficient, asset-light, and cash-generative model, with cost discipline and targeted AUM growth emerging as key drivers. The success of the Profectus merger and sustained margin improvement will be critical to watch, as they will determine whether the company can stabilize returns and regain investor confidence amid a challenging financial services landscape.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when UGROCAP files new disclosures
Track UGROCAP filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track UGROCAP — FreeFree account · 2 AI queries/day